Prosecution Insights
Last updated: April 17, 2026

Guangxi Benpeng Biotechnology Co. Ltd.

1 pending office actions

Portfolio Summary

1
Total Pending OAs
1
Final Rejections
0
Non-Final OAs

Bubble size = number of pending OAs with that examiner. Higher allow rate = easier; higher interview lift = interviews help more.

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17795607 METHOD FOR INDUCING TRANSDIFFERENTIATION OF SOMATIC CELLS INTO MAMMARY EPITHELIAL CELLS IN VITRO USING SMALL MOLECULE COMPOUND MCCORMICK, CATHERINE LYNN 1638 Final Rejection Jul 27, 2022

Managing Guangxi Benpeng Biotechnology Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in for Full Analysis

Enter your email to receive a magic link. No password needed.

Free tier: 3 strategy analyses per month